DESI NDA withdrawal
Executive Summary
FDA announced it is withdrawing approval of NDAs for certain single-entity coronary vasodilators containing pentaerythritol tetranitrate (PETNI since they lack substantial evidence of effectiveness for the prophylactic treatment of angina pectoris. Notice does not apply to nine products for which a hearing was requested.